A Trial Comparing Among Three Bowel Preparation for Colonoscopy

A Prospective Accessor-blinded Randomized Controlled Trial Comparing Among Conventional 4L PEG, Sodium Picosulfate and Magnesium citrate(P/MC), and Low-volume PEG plus Ascorbic acid as Bowel Preparation for Colonoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001005

Enrollment

270

Registered

2014-02-21

Start date

2013-08-05

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Group A, 4 liters of PEG solution taken at 4 hours before procedure on the day of colonoscopy Group B, one of 3 sachets of sodium picosulfate taken at 6 p.m. and 9 p.m. the day before and at 4

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing outpatient elective colonoscopy at Presbyterian medical center

Exclusion criteria

Exclusion criteria: 1.Patients undergoing emergent colonoscopy or patients with bowel perforation or paralysis, toxic megacolon. 2.Patients with severe heart failure, severe renal failure, severe hepatic failure, active inflammatory bowel disease, colon cancer, and other drug contraindication. 3.Patients under 18 years old, pregnant patients, lactating patients. 4.Patients with resection of esophagus, stomach, small bowel, colon.

Design outcomes

Primary

Measure	Time frame
Aronchick bowel preparation scale	—

Secondary

Measure	Time frame
Boston bowel preparation scale;Tolerability;Safety	—

Countries

Korea, Republic of

Contacts

Public ContactMoon Sik Park

Presbyterian Medical Center

Outcome results